Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef5d8f201e1393ffa286163f8ddfc05f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-36 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-36 |
filingDate |
2010-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8e011f4e36abab52338aa9483bbd55b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_833bef36d8b0ae31d9b88a29a750916d |
publicationDate |
2015-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2010212039-C1 |
titleOfInvention |
Contiguous overlapping peptides for treatment of birch pollen allergy |
abstract |
Contiguous overlapping peptides (COPs) for the treatment of allergic patients by Specific Immunotherapy (SIT) are provided from the sequence of the major allergen of birch pollen Bet v 1. Such peptides while providing all potential T cell epitopes are devoid of the 3D structure of the original allergen, therefore reducing their ability to bind IgE. |
priorityDate |
2009-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |